Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
KOREA E & EX

HPV Vaccine Leads to Big Drop in Papilloma Prevalence

By HospiMedica International staff writers
Posted on 03 Jul 2013
Print article
The prevalence of human papillomavirus (HPV) infection in young women has declined by more than half since the introduction of the HPV vaccine, despite low vaccine uptake, claims a new study.

Researchers at the US Centers for Disease Control and Prevention (CDC; Atlanta, GA, USA) conducted a study that analyzed HPV prevalence data from the prevaccine (2003–2006), and the vaccine era (2007–2010), collected from US national health and nutrition examination surveys. HPV prevalence was determined by the linear array assay in cervicovaginal swab samples from females aged 14–59 years; 4,150 women provided samples in 2003–2006, and 4,253 provided samples in 2007–2010.

The results showed that among females aged 14–19 years, the vaccine-type HPV prevalence (HPV-6, -11, -16, or -18) decreased from 11.5% in 2003–2006 to 5.1% in 2007–2010, a decline of 56%. Among other age groups, the prevalence did not differ significantly between the two periods. The researchers stressed that the decline in HPV infection rate occurred despite the fact that only a third of eligible patients received the vaccine, and that vaccine effectiveness of at least one dose was 82%. The study was published in the June 19, 2013, issue of the Journal of Infectious Disease.

“Our data suggest an early impact of HPV vaccination on vaccine type prevalence among females in the United States and high vaccine effectiveness against vaccine type infection,” concluded lead author Lauri Markowitz, MD, and colleagues of the CDC. “The decline in vaccine type prevalence is higher than expected and could be due to herd immunity from vaccination, vaccine effectiveness of a series involving less than three doses, and/or changes in sexual behavior that we did not measure.”

“The results should challenge healthcare professionals to redouble their efforts to improve HPV vaccination rates, which lag far behind many undeveloped nations,” said Anne Schuchat, MD, director of the CDC's National Center for Immunization and Respiratory Diseases. “Here we're finding out about a vaccine that has greater than expected performance even with our pathetic coverage, and I think that this audience of highly motivated immunization experts and clinicians and program staff, I hope, see this as a wake-up call for us to do much better.”

Introduced in 2006, the first HPV vaccine covered the four viral strains most closely associated with gynecologic cancer (HPV-6, 11, 16, and 18). In June 2012, the CDC advisory committee on immunization practices (ACIP) recommended routine vaccination of 11- and 12-year-old girls with three doses of the quadrivalent vaccine, and catch-up vaccination of girls and young women 13 through 26. In 2009, the ACIP updated the recommendation to include the bivalent vaccine (HPV-16 and 18); two years later, ACIP recommended routine vaccination of boys and young men.

Related Links:
US Centers for Disease Control and Prevention



Print article
LevMed LTD.

Channels

Critical Care

view channel
Image: The OsteoCool RF Ablation System (Photo courtesy of Medtronic).

Cooled Ablation System Treats Painful Spine Metastases

A new ablation system uses water-cooled radiofrequency (RF) probes to reduce patient pain when ablating metastatic spinal tumors. The OsteoCool RF Ablation System is intended for palliative treatment... Read more

Surgical Techniques

view channel

Coronary Clot Aspiration Provides No MI Survival Benefit

Thrombectomy did not improve outcomes for myocardial infarct (MI) patients presenting after symptom onset, according to a new study. Researchers at University College London (UCL; United Kingdom), the University of Manchester (United Kingdom), and other institutions conducted a retrospective study based on a UK national... Read more

Health IT

view channel
Image: The Rigel 62353 Plus tester (Photo courtesy of Rigel Medical).

Advanced Safety Tester Analyzes Diverse Medical Devices

An upgraded dedicated tester meets international standards for in-service and post-repair safety testing of 24 V and 48 V DC medical electronic devices. The Rigel 62353 Plus tester offers a range of... Read more

Hospital News

view channel

Geneia Partners with Hospitals on Population Health Training

Geneia (Harrisburg, PA, USA) will provide population health management training to members of the Illinois Health and Hospital Association (IHA; Chicago, USA). Through its education arm, The Geneia Institute, skills-based population health management programs will be delivered to IHA's 209 hospital and nearly 50 health... Read more

Business

view channel

Global Call for Action Against Drug-Resistant Infections

More than 80 leading international bodies came together to call on governments and industry to work in parallel and take comprehensive action against drug-resistant infections, as proclaimed in a joint declaration released at the World Economic Forum (Cologny, Switzerland), held during January 2016 in Davos (Switzerland).... Read more
Copyright © 2000-2016 Globetech Media. All rights reserved.